TPG Inc.

DB:B81 Stock Report

Market Cap: €7.0b

TPG Valuation

Is B81 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of B81 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: B81 (€66) is trading above our estimate of fair value (€12.1)

Significantly Below Fair Value: B81 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for B81?

Key metric: As B81 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for B81. This is calculated by dividing B81's market cap by their current revenue.
What is B81's PS Ratio?
PS Ratio2.2x
SalesUS$3.41b
Market CapUS$7.35b

Price to Sales Ratio vs Peers

How does B81's PS Ratio compare to its peers?

The above table shows the PS ratio for B81 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.4x
DWS DWS Group GmbH KGaA
2x-4.3%€7.8b
DBAN Deutsche Beteiligungs
5.8x41.7%€426.4m
MLP MLP
0.6x2.3%€640.5m
DBK Deutsche Bank
1.1x4.2%€30.5b
B81 TPG
2.2x-6.9%€7.4b

Price-To-Sales vs Peers: B81 is good value based on its Price-To-Sales Ratio (2.2x) compared to the peer average (2.4x).

Price to Sales Ratio vs Industry

How does B81's PS Ratio compare vs other companies in the DE Capital Markets Industry?

22 CompaniesPrice / SalesEstimated GrowthMarket Cap
MLP MLP
0.6x2.3%US$671.02m
MUX Mutares SE KGaA
0.09x10.5%US$507.75m
AR4 AURELIUS Equity Opportunities SE KGaA
0.2x0.01%US$500.05m
AR4 AURELIUS Equity Opportunities SE KGaA
0.1xn/aUS$410.89m
B81 2.2xIndustry Avg. 2.8xNo. of Companies22PS048121620+
22 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: B81 is good value based on its Price-To-Sales Ratio (2.2x) compared to the German Capital Markets industry average (2.8x).

Price to Sales Ratio vs Fair Ratio

What is B81's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

B81 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.2x
Fair PS Ratio2.4x

Price-To-Sales vs Fair Ratio: B81 is good value based on its Price-To-Sales Ratio (2.2x) compared to the estimated Fair Price-To-Sales Ratio (2.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst B81 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€66.00
€62.25
-5.7%
10.1%€72.70€52.88n/a14
Nov ’25€61.00
€56.23
-7.8%
12.4%€67.05€41.33n/a14
Oct ’25€50.50
€46.70
-7.5%
12.9%€56.58€38.62n/a14
Sep ’25€43.80
€44.92
+2.5%
11.0%€56.68€38.69n/a13
Aug ’25€46.20
€44.13
-4.5%
10.7%€55.16€36.77n/a13
Jul ’25€37.80
€44.20
+16.9%
7.2%€49.36€40.05n/a13
Jun ’25€37.60
€44.07
+17.2%
7.3%€49.13€39.86n/a13
May ’25€40.00
€44.45
+11.1%
7.7%€50.73€40.40n/a13
Apr ’25€40.60
€42.39
+4.4%
6.7%€47.92€38.71n/a14
Mar ’25€40.20
€42.39
+5.5%
6.7%€47.92€38.71n/a14
Feb ’25€39.20
€38.07
-2.9%
9.6%€44.11€33.08n/a14
Jan ’25€38.60
€32.69
-15.3%
11.8%€41.22€28.40n/a13
Dec ’24€31.40
€31.29
-0.3%
10.1%€39.19€27.34n/a12
Nov ’24€25.60
€30.45
+18.9%
4.2%€32.10€28.33€61.0012
Oct ’24€28.20
€30.46
+8.0%
6.3%€33.32€26.65€50.5012
Sep ’24€26.00
€29.18
+12.2%
6.5%€32.08€25.66€43.8012
Aug ’24€26.20
€29.69
+13.3%
7.3%€33.93€25.89€46.2012
Jul ’24€27.00
€30.14
+11.6%
11.9%€36.36€25.17€37.8012
Jun ’24€23.60
€30.14
+27.7%
11.9%€36.36€25.17€37.6012
May ’24€25.40
€30.79
+21.2%
9.2%€36.22€27.17€40.0013
Apr ’24€25.40
€32.80
+29.1%
11.3%€39.64€27.66€40.6013
Mar ’24€30.40
€33.71
+10.9%
10.9%€40.57€28.30€40.2013
Feb ’24€29.00
€32.85
+13.3%
11.8%€40.32€27.49€39.2013
Jan ’24€25.80
€34.77
+34.8%
13.4%€45.25€28.28€38.6013
Dec ’23€31.20
€36.24
+16.2%
15.3%€47.55€29.12€31.4013
Nov ’23€30.40
€32.72
+7.6%
10.7%€40.94€28.15€25.6013

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

ORIX

JP¥3.8t

Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.

OIX

JP¥20.40

7D

1.0%

1Y

22.2%

Exor

€20.6b

Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.

EYX

€95.55

7D

2.9%

1Y

8.8%

Merchants Bancorp

US$1.9b

Operates as the diversified bank holding company in the United States.

3KD

US$39.00

7D

6.6%

1Y

29.1%